Search results
Japan's Takeda Pharma Outlines $900M Overhaul To Boost Growth, As 2023 Profit Fall Over 50%
Benzinga via Yahoo Finance· 5 days agoOn Thursday, Japan’s drugmaker Takeda Pharmaceutical Company Limited (NYSE:TAK) announced a...
US FDA extends review of Ascendis Pharma's hormone disorder therapy
Reuters· 9 hours ago, opens new tab therapy to treat adult patients with a hormone disorder by three months, the company...
Health Care Climbs as Obesity-Drug Optimism Returns - Health Care Roundup
Morningstar· 5 days agoHealth-care companies rose as optimism about a boom in obesity drugs regained momentum. Novo Nordisk shares ticked up after the maker of obesity injection Wegovy unveiled a research project aimed at adding up to two more obesity treatments to its
Improving the safety of iPS cell-derived pancreatic islets by eliminating unwanted cells
Medical Xpress· 2 days agoLtd., and Axcelead Drug Discovery Partners, Inc. The potential of iPS cells to become nearly any cell type in the body also creates concerns about possible risks of...
Alzheimer’s vaccine licensing deal boosts AC Immune
Market Watch· 2 days agoThe deal gives Japanese drugmaker Takeda the exclusive option to license global rights to the vaccine, known as ACI-24.060, which is designed to delay or...
A Five-Pillar Process To Develop Sales Leaders
Forbes· 7 days agoFor a best-in-class example, I had the opportunity to connect with the field leader development team (FLD), that is part of US Commercial Learning & Development at Takeda ...
How Neurocrine Is Stacking Up Wins In 2024 — And Outperforming Peers
Investor's Business Daily· 6 days agoIn simple terms, NBI-1065845 works by stimulating neurons in the brain responsible for making...
Bernard Horn's Strategic Moves in Q1 2024: Spotlight on Avnet In
Guru Focus· 4 days agoInsights into Polaris Global Value Fund's Latest Portfolio Adjustments Bernard Horn (Trades, Portfolio), a seasoned investment manager since the early 1980s, l
Companies Cannot Afford to Lag Behind on Implementing AI
The Conference Board· 7 days agoThe following are some key insights from our recent roundtable, What’s the Latest on AI in Communications?, held in partnership with Takeda Pharmaceuticals
Bernard Horn's Strategic Moves in Q1 2024: Spotlight on Avnet Inc
GuruFocus.com via Yahoo Finance· 4 days agoNoteworthy additions include: LKQ Corp (NASDAQ:LKQ), with 105,000 shares, making up 1.32% of the...
